Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (31)

2022

  1. Activation of Hypothalamic AMP-Activated Protein Kinase Ameliorates Metabolic Complications of Experimental Arthritis

    Arthritis and Rheumatology, Vol. 74, Núm. 2, pp. 212-222

2021

  1. Correction to: Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2‑positive breast cancer? (Virchows Archiv, (2021), 479, 4, (853-857), 10.1007/s00428-021-03104-7)

    Virchows Archiv

  2. Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?

    Virchows Archiv, Vol. 479, Núm. 4, pp. 853-857

2019

  1. Hypothalamic dopamine signalling regulates brown fat thermogenesis

    Nature Metabolism, Vol. 1, Núm. 8, pp. 811-829

2018

  1. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis

    Virchows Archiv, Vol. 472, Núm. 2, pp. 195-203

  2. Erratum to: Obestatin controls skeletal muscle fiber-type determination (Scientific Reports, (2017), 7, 1, (2137), 10.1038/s41598-017-02337-4)

    Scientific Reports

  3. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 9, Núm. 6, pp. 1063-1078

2017

  1. Obestatin Increases the Regenerative Capacity of Human Myoblasts Transplanted Intramuscularly in an Immunodeficient Mouse Model

    Molecular Therapy, Vol. 25, Núm. 10, pp. 2345-2359

  2. Obestatin controls skeletal muscle fiber-type determination

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone–induced liver damage through inflammation and endoplasmic reticulum stress

    Hepatology, Vol. 64, Núm. 4, pp. 1086-1104

  2. The role of the obestatin/GPR39 system in human gastric adenocarcinomas

    Oncotarget, Vol. 7, Núm. 5, pp. 5957-5971

  3. β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 3, pp. 617-635

2015

  1. Action of obestatin in skeletal muscle repair: Stem cell expansion, muscle growth, and microenvironment remodeling

    Molecular Therapy, Vol. 23, Núm. 6, pp. 1003-1021

2014

  1. Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance

    Cell Reports, Vol. 9, Núm. 1, pp. 366-377

2013

  1. Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways

    Gastroenterology, Vol. 144, Núm. 3

2012

  1. The NMR Structure of Human Obestatin in Membrane-Like Environments: Insights into the Structure-Bioactivity Relationship of Obestatin

    PLoS ONE, Vol. 7, Núm. 10

  2. The obestatin/GPR39 system is up-regulated by muscle injury and functions as an autocrine regenerative system

    Journal of Biological Chemistry, Vol. 287, Núm. 45, pp. 38379-38389

2011

  1. Obestatin as a regulator of adipocyte metabolism and adipogenesis

    Journal of Cellular and Molecular Medicine, Vol. 15, Núm. 9, pp. 1927-1940

  2. Preproghrelin expression is a key target for insulin action on adipogenesis

    Journal of Endocrinology, Vol. 210, Núm. 2

  3. The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system

    Molecular Biology of the Cell, Vol. 22, Núm. 21, pp. 4182-4191